Skip to main content

Languages

  • العربية
  • 简体中文
  • English
  • Français
  • Русский
  • Español
Home
  • Browse States Parties
  • About CBM
  • CBM Guide
    • English
    • Chinese
    • French
    • Russian
    • Spanish
    • Arabic
  • Log in

You are here

Home » Canada » bwc_cbm_2019_Canada_Fr » Confidence-Building Measure G
Download

    Immunovaccine

    2. Location (mailing address)
    Halifax (Nouvelle-Écosse)
    3. General description of the types of diseases covered

    Fabricant de vaccins (en attente de la licence de production de vaccins destinés aux humains)

    Report Index

    • Cover page declaration (“Form 0”)
    • A, part 1
    • A, part 2 (i)
    • A, part 2 (ii)
    • A, part 2 (iii)
    • B
    • C
    • E
    • F
    • G
        • Gallant Custom Laboratories Inc. (Perm. can. établ. prod. biol. vét. No 45)
        • Novartis Animal Health Canada Inc. (Perm. can. établ. prod. biol. vét. No 40)
        • Prevtec Microbia Inc. (Perm. can. établ. prod. biol. vét. No 60)
        • Saskatoon Colostrum Co. Ltd. (Perm. can. établ. prod. biol. vét. No 44)
        • Biovet Inc. (Perm. can. établ. prod. biol. vét. No 59)
        • ‹ previous
        • 2 of 2
        •  

    BWC Electronic Confidence Building Measures Portal

    Copyright (c) UNOG 2018

     

    Biological Weapons Convention Implementation Support Unit

    Palais des Nations, 1211 Geneva 10, Switzerland
    Phone: +41 (0)22 917 2230
    E-mail: bwc@un.org
    UN logo